EICM Offering
Attomarker is a diagnostics company in Milltrust’s British Innovation Fund portfolio. It is launching a new, simple to use, point-of-care blood testing device that can perform 7 simultaneous tests your GP would request from a single pin-prick of blood in less than five minutes. The patented Attomarker technology uses a disposable credit-card sized chip that slots into a handheld device docked to your iPhone which will provide rapid testing for the healthcare professional and the consumer markets.

Attomarker is looking to secure £7.5M of Series B funding – £2.5M committed, to address a UK market opportunity of £5bn scalable to the rest of the world.